Finance committee  Mr. Chair, members of the committee, on behalf of Bioniche Life Sciences, thank you for this opportunity. Bioniche Life Sciences is an innovative Canadian biopharmaceutical company based in Belleville, Ontario. Our mandate is to act on innovation and to improve the quality of li

Finance committee  It's possible that they may be; however, the biggest issue is that the vaccine does not benefit the cattlemen, the segment it's going to. So I'm not sure that it fits totally within their--

Finance committee  Since our initial request, we've had some feedback that it may not be appropriately funded through there.

Finance committee  The negative impact would be that this adoption would be very limited and hence the investment that's been made in this innovation would really be unrealized. There is a small segment of the industry that will adopt its use, but it is a fraction of the industry. Unfortunately whe

Finance committee  That's absolutely correct. The farming community, they're great people. In many ways they're the backbone of our industry. They are ready to administer it.

Finance committee  Very much so. The U.S., of course, will be the next market. We've already started the regulatory process with them, and we've budgeted or planned forward to certainly go to Europe after that, and then following that, into some of the bigger cattle-producing nations such as those

Finance committee  It's in the initial stages right now. As long as we get momentum and we start to get some payback for the innovation we've already invested in, it's realistic to expect those other things to evolve over the next five to ten years.

Finance committee  E. coli is a normal family of bacteria that lives in the intestines of all mammals. One strain is a mutation that first appeared about 20 years ago. Part of the mutation took place, I guess, when it found a natural host in ruminants, because they're not susceptible to the toxin i

Finance committee  Mr. Chair, members of the committee, on behalf of Bioniche Life Sciences, thank you for this opportunity. Bioniche is an innovative bio-pharmaceutical company based in Belleville, Ontario. Our mandate is to act on innovation and to improve quality of life. We are publicly traded

Finance committee  Thank you for your question. The demonstration projects that we're trying to facilitate right now have basically two elements. One element is that they would measure in the environment, where the vaccine is being used, the reduction of E. coli. Again, it's naturally coming out

Finance committee  We're working on some international submissions right now in the U.S. and Australia. Again, Canada deserves some credit here, but the challenge for regulators is to think outside the box. Every other cattle vaccine that's registered in Canada and elsewhere in the world up until n

Finance committee  We started on this in 2001, as I recall. So it's been about eight or nine years now.

Finance committee  No, I think it would be similar. Biologics or vaccines, as a rule, may not have quite as exhaustive mechanistic studies because, again, you're not putting anything in their system, such as a chemical; you're just stimulating the immune system to put up its natural defences agains

Finance committee  Yes, I do. Very much so.

Finance committee  Oh yes, I think so. I think in terms of job creation in Canada, increasing the volume of vaccine we produce for sale to other countries is a distinct possibility, as people learn how to use this out-of-the-box, innovative technology.